Stocksigma LogoStocksigma Logo

Ennature Bio Pharma Secures BSE and NSE Listing Approvals Post-Demerger

Ennature Bio Pharma Limited received listing and trading approvals from BSE and NSE on 2nd Nov'26 for 2,23,42,255 equity shares (face value Rs

Ennature Bio Pharma Secures BSE and NSE Listing Approvals Post-Demerger

India Glycols Ltd 路 Others (Uncategorized) 路 03 Nov 2026, 4:46 am

Ennature Bio Pharma Secures BSE and NSE Listing Approvals Post-Demerger Ennature Bio Pharma Limited received listing and trading approvals from BSE and NSE on 2nd Nov'26 for 2,23,42,255 equity shares (face value Rs. 5 each), allotted pursuant to the Scheme of Arrangement involving India Glycols Limited and IGL Spirits Limited. Trading in the equity shares is scheduled to commence on 4th Nov'26 across both exchanges.

Original exchange filing (PDF)

More announcements from India Glycols Ltd

All India Glycols Ltd announcements